期刊文献+

CSI监测在肝血管瘤射频消融术中的应用

The Application of CSI Monitoring in Radiofrequency Ablation ofH epatic Hemangioma
下载PDF
导出
摘要 目的:探讨CSI监测在肝血管瘤射频消融术中的应用。方法拟行肝血管瘤射频消融术的患者80例,随机分为N组(对照组)与C组(接受麻醉深度监测),两组患者均采用丙泊酚与瑞芬太尼维持麻醉。 N组患者采用丙泊酚TCI加瑞芬太尼维持麻醉,C组患者以CSI指数40-60为目标调节麻醉药物输注速度。结果 C组患者在术中使用丙泊酚总量、睁眼时间、拔管时间、PACU恢复时间均低于N组患者,差异有统计学意义( P〈0.05)。结论 CSI监测能合理指导麻醉药物用量及减少患者麻醉恢复时间。 Objective To investigate the application of CSI monitoring in radiofrequency ablation of hepatic hemangioma. Methods 80 Patients undergoing radiofrequency ablation of hepatic hemangioma were randomly divided into group N ( control group)and group C(accepting monitoring of anesthesia depth),two groups were both treated with propofol and remifentanil to maintain anesthetic. Group N were treated with propofol and remifentanil to maintain anesthetic,group C were treated with adjustment of narcotic drug′s infusion rate,with the goal of CSI index 40-60. Results The intraoperative use of propofol,eye opening-time,extubation time,PACU recovery time in Group C were all lower than group N(P〈0. 05). Conclusion CSI monitoring can reasonably guide the dosage of narcotic drugs and reduce the amount of recovery time of anesthesia.
出处 《四川医学》 CAS 2016年第10期1163-1165,共3页 Sichuan Medical Journal
关键词 射频消融术 麻醉深度指数 丙泊酚 瑞芬太尼 radiofrequency ablation depth of anesthesia index propofol remifentanil
  • 相关文献

二级参考文献33

  • 1Yoo K, Jeong S W, Kim S J, et al. Cardiovasculur responses to endotracheal intubation in patients with acute and chronic spinal cord injuries[J]. Anesth Analg, 2003, 97 (4) : 1162-1167.
  • 2Gerlach A T, Murphy C U, Dasta J F. An updated focused review of dexmedetomidine in adults[J]. Ann Pharmacother, 2009, 43 ( 12 ) : 2064-2074.
  • 3Kuuisawa T, Nagata O, Nagashima M, et al. Dexmedetomidiue suppresses the decrease in blood pressure during anesthetic induction andblunts the cardiovascular response to tracheal intubation[J]. J ClinAnesth, 2009, 21 (3) : 194-199.
  • 4Su F, Hammer G B. Dexmedetomidine: pediatric pharmacology, clinical uses and safety[J]. Expert Opin Drug Saf, 2011, 10 ( 1 ) : 55-66.
  • 5Ihacache M, Sanchez G, Pedrozo Z, et al. Dexmedetomidiue preconditioning activates pro-survival kinases and attenuates regional ischemia/reperfusion injury in rat heart[J]. Biochim Biophys Acta, 2012, 1822 (4): 537-545.
  • 6Biccard B M, Goga S. de Beurs J. Dexmedetomidine and cardiac protection for non-cardiac surgery : a meta-analysis of randomised controlled trials[J]. Anaesthesia, 2008, 63 ( 1 ) : 4-14.
  • 7Lam F, Bhutta A T, Tobias J D, et al. Hemodynamic effects of dexmedetomidine in critically Ⅲ neonates and infants with heart disease[J]. Pediatr Cardiol, 2012, 34 ( 1 ) : 276-279.
  • 8Taehibana K, Hashimoto T, Kato R, et al. Neonatal administration with dexmedetomidine does not impair the rat hippocampal synaptic plasticity later in adulthood[J]. Paediatr Anaesth, 2012, 10 ( 11 111 ) : 1460-1462.
  • 9Marana E, Colicci S, Meo F, et al. Neuroendocrine stress re- sponse in gynecological laparoscopy: TIVA with propfol versus sevoflurane anesthesia [J]. J Clin Anesth, 2010,22 (4) : 250-255.
  • 10李慧芬,刘保江.瑞芬太尼和舒芬太尼的靶控输注[J].医学综述,2008,14(9):1389-1391. 被引量:22

共引文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部